Quick Answer
Bio Green Med Solution, Inc. reported R&D Expense of $848.0 thousand for fiscal year 2025.
Bio Green Med Solution, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $848.0K | -87.3% |
| 2024 | $6.66M | -65.3% |
| 2023 | $19.16M | -5.5% |
| 2022 | $20.27M | +31.0% |
| 2021 | $15.48M | +225.2% |
| 2020 | $4.76M | +2.2% |
| 2019 | $4.66M | +7.6% |
| 2018 | $4.33M | +2.1% |
| 2017 | $4.24M | -55.3% |
| 2016 | $9.48M | -23.5% |
| 2015 | $12.38M | -32.3% |
| 2014 | $18.28M | +62.1% |
| 2013 | $11.28M | +71.1% |
| 2012 | $6.59M | -28.4% |
| 2011 | $9.21M | +43.5% |
| 2010 | $6.41M | -34.3% |
| 2009 | $9.77M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.0K | -99.5% | -92.6% |
| June 30, 2025 | $68.0K | -96.6% | -91.7% |
| March 31, 2025 | $822.0K | -70.7% | -13.5% |
| September 30, 2024 | $950.0K | -81.9% | -53.0% |
| June 30, 2024 | $2.02M | -57.2% | -27.8% |
| March 31, 2024 | $2.80M | -50.6% | -46.5% |
| September 30, 2023 | $5.24M | +18.6% | +10.8% |
| June 30, 2023 | $4.73M | +12.4% | -16.7% |
- Bio Green Med Solution, Inc. showed a decrease of -87.3% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, Bio Green Med Solution, Inc.’s r&d expense has declined by 91.3% (from $9.77 million to $848.0 thousand).
- The most recent figure is from Bio Green Med Solution, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: